510(k) Report

PMA · Approved

Approved

remede® System

P160039PMAApproved Oct 6, 2017395-day reviewClass III

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Respicardia · PSR Implanted Phrenic Nerve Stimulator For Central Sleep Apnea

Approved on Oct 6, 2017 through premarket approval, which rests on the device’s own clinical evidence after a 395-day review.

Decided
Oct 6, 2017
Review
395 days
Class
Class III
Product code
PSR
Recalls
None

PMA approvals rest on their own clinical evidence and do not claim a predicate, so this family tree starts here.

P160039 has 10 supplements since 2017: changes to the approved device, its labelling or its manufacturing, each approved separately.

PMA supplements approved per year

2017: 12018: 22019: 22021: 12022: 12023: 22025: 1
2017high 2 (2018) · low 0 (2020)2025
View FIG. 1 as a table
YearSupplements approved
20171
20182
20192
20211
20221
20232
20251
FIG. 1 — Supplements to P160039, 2017–2025Source: FDA PMA database

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in PSR? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

Does it have a predicate?

PMA decisions do not claim a predicate device.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All PSR devices

PSR Implanted Phrenic Nerve Stimulator For Central Sleep Apnea: FDA decisions, review times, recalls and adverse event reports over 20 years. 2017, this device’s year, is highlighted.

FDA decisions per year · PSR

1in 2025

2017: 22018: 22019: 22021: 12022: 12023: 22025: 1
2007high 2 (2017) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PSR

Too few PSR 510(k)s in any year since 2007 to give a median.

Recalls per year · PSR

No recall names PSR since 2007.

Adverse event reports per year · PSR

6in 2025

2022: 22025: 6
2007high 6 (2025) · low 0 (2007)2025

MAUDE reports naming product code PSR, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20172—00
20182—00
20192—00
20200—00
20211—00
20221—02
20232—00
20240—00
20251—06
20260—0—
Cite this page

510(k) Report. “P160039: remede® System.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/P160039

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026